Inherited clinical disorders of lipid metabolism

Current Problems in Dermatology

Volumn 39, Issue , 2010, Pages 30-88

  Elias, Peter M ^a   Williams, Mary L ^a   Crumrine, Debra ^a   Schmuth, Matthias ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL SULFATE; FATTY ACID; SPHINGOLIPID;

AUTOSOMAL RECESSIVE DISORDER; BIOCHEMISTRY; CHANARIN DORFMAN SYNDROME; CHOLESTEROL METABOLISM; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ELECTRON MICROSCOPY; FATTY ACID METABOLISM; GAUCHER DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HARLEQUIN ICHTHYOSIS; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; ICHTHYOSIS PREMATURITY SYNDROME; LIPID METABOLISM; LIPIDOSIS; MISSENSE MUTATION; MOLECULAR GENETICS; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PHASE SEPARATION; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW; SJOEGREN LARSSON SYNDROME; SYNDROME CHILDS; ULTRASTRUCTURE; X LINKED ICHTHYOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FATTY ACIDS; FEMALE; FETAL DISEASES; GENES, RECESSIVE; HUMANS; ICHTHYOSIS; INFANT; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MALE; METABOLISM, INBORN ERRORS; MUTATION; SPHINGOLIPIDS;

EID: 77957736350     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000321084     Document Type: Review

References (261)

1. Swanbeck G: The ichthyosis. Acta Derm Venereol Suppl (Stockh) 1981;95:88-90.
2. Williams ML, Elias PM: Heterogeneity in autosomal recessive ichthyosis: Clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1985;121:477-488.
3. Arnold ML, Anton-Lamprecht I, Melz-Rothfuss B, Hartschuh W: Ichthyosis congenita type III: Clinical and ultrastructural characteristics and distinction within the heterogeneous ichthyosis congenita group. Arch Dermatol Res 1988;280:268-278.
4. Ghadially R, Williams ML, Hou SY, Elias PM: Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol 1992;99:755-763.
5. Eckl KM, de Juanes S, Kurtenbach J, et al: Molecular analysis of 250 patients with autosomal recessive congenital ichthyosis: Evidence for mutation hotspots in ALOXE3 and allelic heterogeneity in ALOX12B. J Invest Dermatol 2009;129:1421-1428.
6. Russell LJ, Di Giovanna JJ, Rogers GR, et al: Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995;9:279-283.
7. Huber M, Rettler I, Bernasconi K, et al: Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995;267:525-528.
8. Hennies HC, Kuster W, Wiebe V, Krebsova A, Reis A: Genotype/phenotype correlation in autosomal recessive lamellar ichthyosis. Am J Hum Genet 1998;62:1052-1061.
9. Jobard F, Lefevre C, Karaduman A, et al: Lipoxygenase-3 (ALOXE3) and 12R-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. Hum Mol Genet 2002;11:107-113.
10. Akiyama M, Sawamura D, Shimizu H: The clinical spectrum of nonbullous congenital ichthyosiform erythroderma and lamellar ichthyosis. Clin Exp Dermatol 2003;28:235-240.
11. Vahlquist A, Ganemo A, Pigg M, Virtanen M, Westermark P: The clinical spectrum of congenital ichthyosis in Sweden: A review of 127 cases. Acta Derm Venereol Suppl (Stockh) 2003;83:34-47.
12. Eckl KM, Krieg P, Kuster W, et al: Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis. Hum Mutat 2005;26:351-361.
13. Fischer J, Faure A, Bouadjar B, et al: Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity. Am J Hum Genet 2000;66: 904-913.
14. Richard G: Molecular genetics of the ichthyoses. Am J Med Genet C Semin Med Genet 2004;131C:32-44.
15. Anton-Lamprecht I: Ultrastructural identification of basic abnormalities as clues to genetic disorders of the epidermis. J Invest Dermatol 1994;103:6S- 12S.
16. Williams ML: Ichthyosis: Mechanisms of disease. Pediatr Dermatol 1992;9:365-368.
17. Williams ML: Epidermal lipids and scaling diseases of the skin. Semin Dermatol 1992;11:169-175.
18. Fischer J: Autosomal recessive congenital ichthyosis. J Invest Dermatol 2009;129:1319-1321.
19. Elias PM, Williams ML, Holleran WM, Jiang YJ, Schmuth M: Pathogenesis of permeability barrier abnormalities in the ichthyoses: Inherited disorders of lipid metabolism. J Lipid Res 2008;49:697-714.
20. Lefevre C, Audebert S, Jobard F, et al: Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum Mol Genet 2003;12:2369-2378.
21. Vahlquist A, Bygum A, Ganemo A, et al: Genotypic and clinical spectrum of self-improving collodion ichthyosis: ALOX12B, ALOXE3, and TGM1 mutations in Scandinavian patients. J Invest Dermatol 2010;130:438-443.
22. Farasat S, Wei MH, Herman M, et al: Novel transglutaminase- 1 mutations and genotype-phenotype investigations of 104 patients with autosomal recessive congenital ichthyosis in the USA. J Med Genet 2009;46:103-111.
23. Harting M, Brunetti-Pierri N, Chan CS, et al: Selfhealing collodion membrane and mild nonbullous congenital ichthyosiform erythroderma due to 2 novel mutations in the ALOX12B gene. Arch Dermatol 2008;144:351-356.
24. Hohl D, Williams ML: Ichthyoses and related mendelian disorders of cornification (MEDOC); in Irvine A, Hoger P, Yan A (eds): Textbook of Pediatric Dermatology. In press.
25. Klar J, Schweiger M, Zimmerman R, et al: Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. Am J Hum Genet 2009;85:248-253.
26. Sakai K, Akiyama M, Yanagi T, et al: ABCA12 is a major causative gene for non-bullous congenital ichthyosiform erythroderma. J Invest Dermatol 2009;129:2306-2309.
27. Hallopeau H, Watelet R: Sur une forme attenuee de la maladie dite ichtyose foetale. Ann Dermatol Syphilol 1884;3:149-152.
28. Van Gysel D, Lijnen RL, Moekti SS, de Laat PC, Oranje AP: Collodion baby: A follow-up study of 17 cases. J Eur Acad Dermatol Venereol 2002;16:472-475.
29. Lawlor F: Progress of a harlequin fetus to nonbullous ichthyosiform erythroderma. Pediatrics 1988;82:870-873.
30. Lefevre C, Bouadjar B, Karaduman A, et al: Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis. Hum Mol Genet 2004;13:2473-2482.
31. Lesueur F, Bouadjar B, Lefevre C, et al: Novel mutations in ALOX12B in patients with autosomal recessive congenital ichthyosis and evidence for genetic heterogeneity on chromosome 17p13. J Invest Dermatol 2007;127:829-834.
32. Dahlqvist J, Klar J, Hausser I, et al: Congenital ichthyosis: Mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis. J Med Genet 2007;44:615-620.
33. Zeeuwen PL, Cheng T, Schalkwijk J: The biology of cystatin M/E and its cognate target proteases. J Invest Dermatol 2009;129:1327-1338.
34. Oji V, Zeeuwen P, Schalkwijk J, Traupe H: Evaluation of cystatin M/E: A candidate for cornification disorders. Arch Dermatol Res 2005;296:408.
35. Anton R, Vila L: Stereoselective biosynthesis of hepoxilin B3 in human epidermis. J Invest Dermatol 2000;114:554-559.
36. Anton R, Camacho M, Puig L, Vila L: Hepoxilin B3 and its enzymatically formed derivative trioxilin B3 are incorporated into phospholipids in psoriatic lesions. J Invest Dermatol 2002;118:139-146.
37. Krieg P, Marks F, Furstenberger G: A gene cluster encoding human epidermis-type lipoxygenases at chromosome 17p13.1: Cloning, physical mapping, and expression. Genomics 2001;73:323-330.
38. Yu Z, Schneider C, Boeglin WE, Marnett LJ, Brash AR: The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc Natl Acad Sci USA 2003;100:9162-9167.
39. Yu Z, Schneider C, Boeglin WE, Brash AR: Mutations associated with a congenital form of ichthyosis (NCIE) inactivate the epidermal lipoxygenases 12RLOX and eLOX3. Biochim Biophys Acta 2005; 16863:238-247.
40. Epp N, Furstenberger G, Muller K, et al: 12R-Lipoxygenase deficiency disrupts epidermal barrier function. J Cell Biol 2007;177:173-182.
41. Moran JL, Qiu H, Turbe-Doan A, et al: A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts formation of the epidermal permeability barrier. J Invest Dermatol 2007;127:1893-1897.
42. Schmuth M, Gruber R, Elias PM, Williams M: Ichthyosis update: Towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders. Adv Dermatol 2007;23:231-256.
43. Lefevre C, Bouadjar B, Ferrand V, et al: Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum Mol Genet 2006;15:767-776.
44. Brash AR, Yu Z, Boeglin WE, Schneider C: The hepoxilin connection in the epidermis. FEBS J 2007; 274:3494-3502.
45. Williams ML, Coleman RA, Placezk D, Grunfeld C: Neutral lipid storage disease: A possible functional defect in phospholipid-linked triacylglycerol metabolism. Biochim Biophys Acta 1991;1096:162-169.
46. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R: Neutral lipid storage disease: Genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab 2009;297:E289-E296.
47. Elias PM, Brown BE: The mammalian cutaneous permeability barrier: Defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest 1978; 39:574-583.
48. Elias PM, Brown BE, Ziboh VA: The permeability barrier in essential fatty acid deficiency: Evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol 1980;74:230-233.
49. Nugteren DH, Christ-Hazelhof E, van der Beek A, Houtsmuller UM: Metabolism of linoleic acid and other essential fatty acids in the epidermis of the rat. Biochim Biophys Acta 1985;834:429-436.
50. Hou SY, Mitra AK, White SH, Menon GK, Ghadially R, Elias PM: Membrane structures in normal and essential fatty acid-deficient stratum corneum: Characterization by ruthenium tetroxide staining and X-ray diffraction. J Invest Dermatol 1991;96: 215-223.
51. Yu Z, Schneider C, Boeglin WE, Brash AR: Epidermal lipoxygenase products of the hepoxilin pathway selectively activate the nuclear receptor PPARalpha. Lipids 2007;42:491-497.
52. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S: Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998;111:1116-1121.
53. Hanley K, Jiang Y, He SS, et al: Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha. J Invest Dermatol 1998;110:368-375.
54. Sheu MY, Fowler AJ, Kao J, et al: Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 2002; 118:94-101.
55. Schmuth M, Schoonjans K, Yu QC, et al: Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero. J Invest Dermatol 2002;119:1298-1303.
56. Dubrac S, Stoitzner P, Pirkebner D, et al: Peroxisome proliferator-activated receptor-alpha activation inhibits Langerhans cell function. J Immunol 2007;178: 4362-4372.
57. Cowart LA, Wei S, Hsu MH, et al: The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator- activated receptor ligands. J Biol Chem 2002;277:35105-35112.
58. Reynaud D, Demin PM, Sutherland M, Nigam S, Pace-Asciak CR: Hepoxilin signaling in intact human neutrophils: Biphasic elevation of intracellular calcium by unesterified hepoxilin A3. FEBS Lett 1999;446:236-238.
59. Lavrijsen AP, Bouwstra JA, Gooris GS, Weerheim A, Bodde HE, Ponec M: Reduced skin barrier function parallels abnormal stratum corneum lipid organization in patients with lamellar ichthyosis. J Invest Dermatol 1995;105:619-624.
60. Elias PM, Schmuth M, Uchida Y, et al: Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol 2002;11:248-256.
61. De Juanes S, Epp N, Latzko S, et al: Development of an ichthyosiform phenotype in Alox12b-deficient mouse skin transplants. J Invest Dermatol 2009;129: 1429-1436.
62. Ganemo A, Pigg M, Virtanen M, et al: Autosomal recessive congenital ichthyosis in Sweden and Estonia: Clinical, genetic and ultrastructural findings in eighty-three patients. Acta Derm Venereol 2003;83:24-30.
63. Bouwstra JA, Ponec M: The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758:2080-2095.
64. Natsuga K, Akiyama M, Kato N, et al: Novel ABCA12 mutations identified in two cases of nonbullous congenital ichthyosiform erythroderma associated with multiple skin malignant neoplasia. J Invest Dermatol 2007;127:2669-2673.
65. Elias PM, Williams ML: Neutral lipid storage disease with ichthyosis: Defective lamellar body contents and intracellular dispersion. Arch Dermatol 1985;121:1000-1008.
66. Demerjian M, Crumrine DA, Milstone LM, Williams ML, Elias PM: Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin-Dorfman syndrome). J Invest Dermatol 2006;126:2032-2038.
67. Williams ML, Koch TK, McDonnell JJ, et al: Ichthyosis and neutral-lipid storage disease. Am J Med Genet 1985;20:711-726.
68. Pujol RM, Gilaberte M, Toll A, et al: Erythrokeratoderma variabilis-like ichthyosis in Chanarin- Dorfman syndrome. Br J Dermatol 2005;153: 838-841.
69. Solomon C, Bernier L, Germain L, Dufour R, Davignon J: Severe oily ichthyosis in monozygotic twins mimicking Chanarin-Dorfman syndrome but not associated with a mutation of the CGI58 gene. Arch Dermatol 2006;142:402-403.
70. Ujihara M, Nakajima K, Yamamoto M, et al: Epidermal triglyceride levels are correlated with severity of ichthyosis in Dorfman-Chanarin syndrome. J Dermatol Sci 20010;57:102-107.
71. Lefevre C, Jobard F, Caux F, et al: Mutations in CGI- 58, the gene encoding a new protein of the esterase/ lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 2001;69:1002-1012.
72. Akiyama M, Sawamura D, Nomura Y, Sugawara M, Shimizu H: Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome. J Invest Dermatol 2003;121:1029-1034.
73. Ben Selma Z, Yilmaz S, Schischmanoff PO, et al: A novel S115G mutation of CGI-58 in a Turkish patient with Dorfman-Chanarin syndrome. J Invest Dermatol 2007;127:2273-2276.
74. Fischer J, Lefevre C, Morava E, et al: The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 2007;39:28-30.
75. Lass A, Zimmermann R, Haemmerle G, et al: Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome. Cell Metab 2006;3: 309-319.
76. Radner FP, Streith IE, Schoiswohl G, et al: Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 20010;285:7300-7311.
77. Igal RA, Coleman RA: Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem 1996;271:16644-16651.
78. Igal RA, Coleman RA: Neutral lipid storage disease: A genetic disorder with abnormalities in the regulation of phospholipid metabolism. J Lipid Res 1998; 39:31-43.
79. Man MQ, Feingold KR, Jain M, Elias PM: Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res 1995; 36:1925-1935.
80. Fluhr JW, Elias PM: Stratum corneum pH: Formation and function of the 'acid mantle'. Exog Dermatol 2002;1:163-175.
81. Elias PM, Steinhoff M: 'Outside-to-inside' (and now back to 'outside') pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008;128:1067-1070.
82. Zaynoun ST, Aftimos BG, Tenekjian KK, Bahuth N, Kurban AK: Extensive pityriasis alba: A histological histochemical and ultrastructural study. Br J Dermatol 1983;108:83-90.
83. Johnson BL, Kramer EM, Lavker RM: The keratotic tumors of Cowden's disease: An electronmicroscopic study. J Cutan Pathol 1987;14:291-298.
84. Kanerva L: Electron microscopy of the effects of dithranol on healthy and on psoriatic skin. Am J Dermatopathol 1990;12:51-62.
85. el-Shoura SM, Tallab TM: Richner-Hanhart's syndrome: New ultrastructural observations on skin lesions of two cases. Ultrastruct Pathol 1997;21:51-56.
86. Monteiro-Riviere NA, Inman AO, Riviere JE: Skin toxicity of jet fuels: Ultrastructural studies and the effects of substance P. Toxicol Appl Pharmacol 2004;195:339-347.
87. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991;24:1-26.
88. Yamaguchi T, Omatsu N, Matsushita S, Osumi T: CGI-58 interacts with perilipin and is localized to lipid droplets: Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J Biol Chem 2004;279:30490-30497.
89. Moskowitz DG, Fowler AJ, Heyman MB, et al: Pathophysiologic basis for growth failure in children with ichthyosis: An evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J Pediatr 2004;145:82-92.
90. Uchida Y, Cho YH, Moradian S, et al: Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome. SID 2010 Annu Meet, Atlanta, 2010.
91. Bangham, AD: Lipid bilayers and biomembranes. Annu Rev Biochem 1972;41:753-776.
92. Rehfeld SJ, Williams ML, Elias PM: Interactions of cholesterol and cholesterol sulfate with free fatty acids: Possible relevance for the pathogenesis of recessive X-linked ichthyosis. Arch Dermatol Res 1986;278:259-263.
93. Rehfeld SJ, Plachy WZ, Williams ML, Elias PM: Calorimetric and electron spin resonance examination of lipid phase transitions in human stratum corneum: Molecular basis for normal cohesion and abnormal desquamation in recessive X-linked ichthyosis. J Invest Dermatol 1988;91:499-505.
94. Elias PM, Crumrine D, Rassner U, et al: Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 2004;122: 314-319.
95. Van den Brink DM, Wanders RJ: Phytanic acid: Production from phytol, its breakdown and role in human disease. Cell Mol Life Sci 2006;63:1752-1765.
96. Shibaki A, Akiyama M, Shimizu H: Novel ALDH3A2 heterozygous mutations are associated with defective lamellar granule formation in a Japanese family of Sjogren-Larsson syndrome. J Invest Dermatol 2004;123:1197-1199.
97. Rizzo WB: Sjogren-Larsson syndrome: Molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab 2007;90:1-9.
98. Holleran WM, Ziegler SG, Goker-Alpan O, et al: Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease. Clin Genet 2006; 69:355-357.
99. Emami S, Hanley KP, Esterly NB, Daniallinia N, Williams ML: X-linked dominant ichthyosis with peroxisomal deficiency: An ultrastructural and ultracytochemical study of the Conradi-Hunermann syndrome and its murine homologue, the bare patches mouse. Arch Dermatol 1994;130:325-336.
100. Khnykin D, Crumrine D, Uchida Y, Johansen F, Jahnsen F, Elias P: Epidermal barrier abnormalities and pathogenesis of ichthyosis prematurity syndrome. SID 2010 Annu Meet, Atlanta, 2010.
101. Willemsen MA, Ijlst L, Steijlen PM, et al: Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjogren-Larsson syndrome. Brain 2001;124:1426-1437.
102. Jagell S, Liden S: Ichthyosis in the Sjogren-Larsson syndrome. Clin Genet 1982;21:243-252.
103. Paige DG, Morse-Fisher N, Harper JI: Quantification of stratum corneum ceramides and lipid envelope ceramides in the hereditary ichthyoses. Br J Dermatol 1994;131:23-27.
104. Wedi B, Kapp A: Pathophysiological role of leukotrienes in dermatological diseases: Potential therapeutic implications. Biodrugs 2001;15:729-743.
105. Rizzo WB, Craft DA: Sjogren-Larsson syndrome: Accumulation of free fatty alcohols in cultured fibroblasts and plasma. J Lipid Res 2000;41:1077-1081.
106. Rizzo WB: Sjogren-Larsson syndrome: Explaining the skin-brain connection. Neurology 1999;52:1307-1308.
107. Gordon N: Sjogren-Larsson syndrome. Dev Med Child Neurol 2007;49:152-154.
108. Rizzo WB, S'Aulis D, Jennings MA, Crumrine DA, Williams ML, Elias PM: Ichthyosis in Sjogren- Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion. Arch Dermatol Res 2010, E-pub ahead of print.
109. Jansen GA, Ferdinandusse S, Hogenhout EM, Verhoeven NM, Jakobs C, Wanders RJ: Phytanoyl- CoA hydroxylase deficiency: Enzymological and molecular basis of classical Refsum disease. Adv Exp Med Biol 1999;466:371-376.
110. Blanchet-Bardon C, Anton-Lamprecht I, Puissant A, Schnyder U: Ultrastructural features of ichthyotic skin in Refsum's syndrome; in Marks R, Dykes P (eds): The Ichthyoses. New York, SP Medical & Scientific Books, 1978, pp 65-69.
111. Van den Brink DM, Brites P, Haasjes J, et al: Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet 2003;72:471-477.
112. Pahan K, Khan M, Singh I: Phytanic acid oxidation: Normal activation and transport yet defective alphahydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata. J Lipid Res 1996;37:1137-1143.
113. Emami S, Rizzo WB, Hanley KP, Taylor JM, Goldyne ME, Williams ML: Peroxisomal abnormality in fibroblasts from involved skin of CHILD syndrome: Case study and review of peroxisomal disorders in relation to skin disease. Arch Dermatol 1992;128: 1213-1222.
114. Verhoeven NM, Jakobs C, Carney G, Somers MP, Wanders RJ, Rizzo WB: Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid. FEBS Lett 1998;429:225-228.
115. Happle R: Lyonization and the lines of Blaschko. Hum Genet 1985;70:200-206.
116. Happle R: X-linked dominant chondrodysplasia punctata: Review of literature and report of a case. Hum Genet 1979;53:65-73.
117. Ikegawa S, Ohashi H, Ogata T, et al: Novel and recurrent EBP mutations in X-linked dominant chondrodysplasia punctata. Am J Med Genet 2000; 94:300-305.
118. Steijlen PM, van Geel M, Vreeburg M, et al: Novel EBP gene mutations in Conradi-Hunermann- Happle syndrome. Br J Dermatol 2007;157:1225-1229.
119. Feldmeyer L, Mevorah B, Grzeschik KH, Huber M, Hohl D: Clinical variation in X-linked dominant chondrodysplasia punctata (X-linked dominant ichthyosis). Br J Dermatol 2006;154:766-769.
120. Herman GE, Kelley RI, Pureza V, et al: Characterization of mutations in 22 females with X-linked dominant chondrodysplasia punctata (Happle syndrome). Genet Med 2002;4:434-438.
121. Grange DK, Kratz LE, Braverman NE, Kelley RI: CHILD syndrome caused by deficiency of 3betahydroxysteroid- delta8, delta7-isomerase. Am J Med Genet 2000;90:328-335.
122. Konig A, Happle R, Bornholdt D, Engel H, Grzeschik KH: Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet 2000;90:339-346.
123. Happle R: X-chromosome inactivation: Role in skin disease expression. Acta Paediatr Suppl 2006;95:16-23.
124. Derry JM, Gormally E, Means GD, et al: Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. Nat Genet 1999;22:286-290.
125. Braverman N, Lin P, Moebius FF, et al: Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi- Hunermann syndrome. Nat Genet 1999;22:291-294.
126. Kelley RI, Herman GE: Inborn errors of sterol biosynthesis. Annu Rev Genomics Hum Genet 2001; 2:299-341.
127. Elias P, Williams ML, Maloney M, Fritsch P, Chung J-C: Applications of the diazacholesterol animal model of ichthyosis; in Marks R, Plewig G (eds): Skin Models. Berlin, Springer, 1986, pp 122-135.
128. Elias PM, Lampe MA, Chung JC, Williams ML: Diazacholesterol-induced ichthyosis in the hairless mouse. I. Morphologic, histochemical, and lipid biochemical characterization of a new animal model. Lab Invest 1983;48:565-577.
129. Feingold KR: The regulation and role of epidermal lipid synthesis. Adv Lipid Res 1991;24:57-82.
130. Cooper MK, Wassif CA, Krakowiak PA, et al: A defective response to hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 2003; 33:508-513.
131. Clayton PT, Kalter DC, Atherton DJ, Besley GT, Broadhead DM: Peroxisomal enzyme deficiency in X-linked dominant Conradi-Hunermann syndrome. J Inherit Metab Dis 1989;12(suppl 2):358-360.
132. Holmes RD, Wilson GN, Hajra AK: Peroxisomal enzyme deficiency in the Conradi-Hunerman form of chondrodysplasia punctata. N Engl J Med 1987; 316:1608.
133. Wilson CJ, Aftimos S: X-linked dominant chondrodysplasia punctata: A peroxisomal disorder? Am J Med Genet 1998;78:300-302.
134. Goldyne ME, Williams ML: CHILD syndrome: Phenotypic dichotomy in eicosanoid metabolism and proliferative rates among cultured dermal fibroblasts. J Clin Invest 1989;84:357-360.
135. Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW: Peroxisome biogenesis disorders. Biochim Biophys Acta 2006;1763:1733-1748.
136. Liao H, Waters AJ, Goudie DR, et al: Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 2007;127: 2795-2798.
137. Epstein EH Jr, Krauss RM, Shackleton CH: X-linked ichthyosis: Increased blood cholesterol sulfate and electrophoretic mobility of low-density lipoprotein. Science 1981;214:659-660.
138. Bergner EA, Shapiro LJ: Metabolism of 3H-dehydroepiandrosterone sulphate by subjects with steroid sulphatase deficiency. J Inherit Metab Dis 1988; 11:403-415.
139. Ibsen HH, Brandrup F, Secher B: Topical cholesterol treatment of recessive X-linked ichthyosis. Lancet 1984;ii:645.
140. Shapiro LJ: Steroid sulfatase deficiency and the genetics of the short arm of the human X chromosome. Adv Hum Genet 1985;14:331-381, 388-389.
141. Bradshaw KD, Carr BR: Placental sulfatase deficiency: Maternal and fetal expression of steroid sulfatase deficiency and X-linked ichthyosis. Obstet Gynecol Surv 1986;41:401-413.
142. Lykkesfeldt G, Nielsen MD, Lykkesfeldt AE: Placental steroid sulfatase deficiency: Biochemical diagnosis and clinical review. Obstet Gynecol 1984; 64:49-54.
143. David M, Israel N, Merksamer R, et al: Very low maternal serum unconjugated estriol and prenatal diagnosis of steroid sulfatase deficiency. Fetal Diagn Ther 1995;10:76-79.
144. Schoen E, Norem C, O'Keefe J, Krieger R, Walton D, To TT: Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions. Obstet Gynecol 2003;102:167-172.
145. Lykkesfeldt G, Hoyer H, Lykkesfeldt AE, Skakkebaek NE: Steroid sulphatase deficiency associated with testis cancer. Lancet 1983;ii:1456.
146. Koppe G, Marinkovic-Ilsen A, Rijken Y, De Groot WP, Jobsis AC: X-linked icthyosis: A sulphatase deficiency. Arch Dis Child 1978;53:803-806.
147. Webster D, France JT, Shapiro LJ, Weiss R: X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet 1978;i:70-72.
148. Tiepolo L, Zuffardi O, Rodewald A: Nullisomy for the distal portion of Xp in a male child with a X/Y translocation. Hum Genet 1977;39:277-281.
149. Mohandas T, Shapiro LJ, Sparkes RS, Sparkes MC: Regional assignment of the steroid sulfatase-Xlinked ichthyosis locus: Implications for a noninactivated region on the short arm of human X chromosome. Proc Natl Acad Sci USA 1979;76:5779-5783.
150. Li XM, Yen P, Mohandas T, Shapiro LJ: A long range restriction map of the distal human X chromosome short arm around the steroid sulfatase locus. Nucleic Acids Res 1990;18:2783-2788.
151. Tiepolo L, Zuffardi O, Fraccaro M, et al: Assignment by deletion mapping of the steroid sulfatase X-linked ichthyosis locus to Xp223. Hum Genet 1980;54:205-206.
152. Ballabio A, Parenti G, Carrozzo R, et al: Isolation and characterization of a steroid sulfatase cDNA clone: Genomic deletions in patients with X-chromosome- linked ichthyosis. Proc Natl Acad Sci USA 1987;84:4519-4523.
153. Bonifas JM, Morley BJ, Oakey RE, Kan YW, Epstein EH Jr: Cloning of a cDNA for steroid sulfatase: Frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. Proc Natl Acad Sci USA 1987;84:9248-9251.
154. Conary JT, Lorkowski G, Schmidt B, et al: Genetic heterogeneity of steroid sulfatase deficiency revealed with cDNA for human steroid sulfatase. Biochem Biophys Res Commun 1987;144:1010-1017.
155. Gillard EF, Affara NA, Yates JR, et al: Deletion of a DNA sequence in eight of nine families with X-linked ichthyosis (steroid sulphatase deficiency). Nucleic Acids Res 1987;15:3977-3985.
156. Shapiro LJ, Yen P, Pomerantz D, Martin E, Rolewic L, Mohandas T: Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci USA 1989;86:8477-8481.
157. Schmickel RD: Contiguous gene syndromes: A component of recognizable syndromes. J Pediatr 1986; 109:231-241.
158. Schnur RE, Trask BJ, van den Engh G, et al: An Xp22 microdeletion associated with ocular albinism and ichthyosis: Approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry. Am J Hum Genet 1989; 45:706-720.
159. De Vries B, Eussen B, van Diggelen O, et al: Submicroscopic Xpter deletion in a boy with growth and mental retardation caused by a familial t(X;14). Am J Med Genet A 1999;87:189-194.
160. Willemsen R, Kroos M, Hoogeveen AT, et al: Ultrastructural localization of steroid sulphatase in cultured human fibroblasts by immunocytochemistry: A comparative study with lysosomal enzymes and the mannose 6-phosphate receptor. Histochem J 1988;20:41-51.
161. Dibbelt L, Herzog V, Kuss E: Human placental sterylsulfatase: Immunocytochemical and biochemical localization. Biol Chem Hoppe Seyler 1989;370: 1093-1102.
162. Elias PM, Williams ML, Maloney ME, et al: Stratum corneum lipids in disorders of cornification: Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest 1984;74:1414-1421.
163. Epstein EH, Williams ML, Elias PM: The epidermal cholesterol sulfate cycle. J Am Acad Dermatol 1984; 10:866-868.
164. Long SA, Wertz PW, Strauss JS, Downing DT: Human stratum corneum polar lipids and desquamation. Arch Dermatol Res 1985;277:284-287.
165. Rearick JI, Albro PW, Jetten AM: Increase in cholesterol sulfotransferase activity during in vitro squamous differentiation of rabbit tracheal epithelial cells and its inhibition by retinoic acid. J Biol Chem 1987;262:13069-13074.
166. Rearick JI, Hesterberg TW, Jetten AM: Human bronchial epithelial cells synthesize cholesterol sulfate during squamous differentiation in vitro. J Cell Physiol 1987;133:573-578.
167. Rearick JI, Jetten AM: Accumulation of cholesterol 3-sulfate during in vitro squamous differentiation of rabbit tracheal epithelial cells and its regulation by retinoids. J Biol Chem 1986;261:13898-13904.
168. Jetten AM, George MA, Pettit GR, Herald CL, Rearick JI: Action of phorbol esters, bryostatins, and retinoic acid on cholesterol sulfate synthesis: Relation to the multistep process of differentiation in human epidermal keratinocytes. J Invest Dermatol 1989;93:108-115.
169. Higashi Y, Fuda H, Yanai H, et al: Expression of cholesterol sulfotransferase (SULT2B1b) in human skin and primary cultures of human epidermal keratinocytes. J Invest Dermatol 2004;122:1207-1213.
170. Williams ML, Rutherford SL, Ponec M, Hincenbergs M, Placzek DR, Elias PM: Density-dependent variations in the lipid content and metabolism of cultured human keratinocytes. J Invest Dermatol 1988; 91:86-91.
171. Jetten AM, Brody AR, Deas MA, Hook GE, Rearick JI, Thacher SM: Retinoic acid and substratum regulate the differentiation of rabbit tracheal epithelial cells into squamous and secretory phenotype: Morphological and biochemical characterization. Lab Invest 1987;56:654-664.
172. Kagehara M, Tachi M, Harii K, Iwamori M: Programmed expression of cholesterol sulfotransferase and transglutaminase during epidermal differentiation of murine skin development. Biochim Biophys Acta 1994;1215:183-189.
173. Hanley K, Jiang Y, Katagiri C, Feingold KR, Williams ML: Epidermal steroid sulfatase and cholesterol sulfotransferase are regulated during late gestation in the fetal rat. J Invest Dermatol 1997;108:871-875.
174. Komuves LG, Hanley K, Jiang Y, et al: Induction of selected lipid metabolic enzymes and differentiation- linked structural proteins by air exposure in fetal rat skin explants. J Invest Dermatol 1999;112: 303-309.
175. Jiang YJ, Kim P, Elias PM, Feingold KR: LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes. J Lipid Res 2005;46:2657-2666.
176. Strott CA: Sulfonation and molecular action. Endocr Rev 2002;23:703-732.
177. Strott CA, Higashi Y: Cholesterol sulfate in human physiology: What's it all about? J Lipid Res 2003;44: 1268-1278.
178. Kashiwagi M, Ohba M, Chida K, Kuroki T: Protein kinase C eta (PKC eta): Its involvement in keratinocyte differentiation. J Biochem (Tokyo) 2002;132: 853-857.
179. Denning MF, Dlugosz AA, Williams EK, Szallasi Z, Blumberg PM, Yuspa SH: Specific protein kinase C isozymes mediate the induction of keratinocyte differentiation markers by calcium. Cell Growth Differ 1995;6:149-157.
180. Ikuta T, Chida K, Tajima O, et al: Cholesterol sulfate, a novel activator for the eta isoform of protein kinase C. Cell Growth Differ 1994;5:943-947.
181. Kuroki T, Ikuta T, Kashiwagi M, et al: Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: A review. Mutat Res 2000;462:189-195.
182. Kawabe S, Ikuta T, Ohba M, et al: Cholesterol sulfate activates transcription of transglutaminase 1 gene in normal human keratinocytes. J Invest Dermatol 1998;111:1098-1102.
183. Hanley K, Wood L, Ng DC, et al: Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D. J Lipid Res 2001;42:390-398.
184. Kubilus J, Tarascio AJ, Baden HP: Steroid-sulfatase deficiency in sex-linked ichthyosis. Am J Hum Genet 1979;31:50-53.
185. Williams ML, Elias PM: Stratum corneum lipids in disorders of cornification: Increased cholesterol sulfate content of stratum corneum in
186. Ranasinghe AW, Wertz PW, Downing DT, Mackenzie IC: Lipid composition of cohesive and desquamated corneocytes from mouse ear skin. J Invest Dermatol 1986;86:187-190.
187. Grayson S, Johnson-Winegar AG, Wintroub BU, Isseroff RR, Epstein EH Jr, Elias PM: Lamellar bodyenriched fractions from neonatal mice: Preparative techniques and partial characterization. J Invest Dermatol 1985;85:289-294.
188. Ponec M, Williams ML: Cholesterol sulfate uptake and outflux in cultured human keratinocytes. Arch Dermatol Res 1986;279:32-36.
189. Lavrijsen AP, Oestmann E, Hermans J, Bodde HE, Vermeer BJ, Ponec M: Barrier function parameters in various keratinization disorders: Transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol 1993;129:547-553.
190. Johansen JD, Ramsing D, Vejlsgaard G, Agner T: Skin barrier properties in patients with recessive X-linked ichthyosis. Acta Derm Venereol 1995;75: 202-204.
191. Zettersten E, Man MQ, Sato J, et al: Recessive X-linked ichthyosis: Role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol 1998;111:784-790.
192. Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 1990;86:1738-1745.
193. Williams ML, Rutherford SL, Feingold KR: Effects of cholesterol sulfate on lipid metabolism in cultured human keratinocytes and fibroblasts. J Lipid Res 1987;28:955-967.
194. Frost P, Weinstein GD, Van Scott EJ: The ichthyosiform dermatoses. II. Autoradiographic studies of epidermal proliferation. J Invest Dermatol 1966;47: 561-567.
195. Ekholm IE, Brattsand M, Egelrud T: Stratum corneum tryptic enzyme in normal epidermis: A missing link in the desquamation process? J Invest Dermatol 2000;114:56-63.
196. Sato J, Denda M, Nakanishi J, Nomura J, Koyama J: Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum. J Invest Dermatol 1998;111:189-193.
197. Williams ML: Lipids in normal and pathological desquamation. Adv Lipid Res 1991;24:211-262.
198. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM: PH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003;121:345-353.
199. Hachem JP, Fowler A, Behne M, Fluhr J, Feingold K, Elias P: Increased stratum corneum pH promotes activation and release of primary cytokines from the stratum corneum attributable to activation of serine proteases. J Invest Dermatol 2002;119:258.
200. Hachem JP, Roelandt T, Schurer N, et al: Acute acidification of stratum corneum membrane domains using polyhydroxyl acids improves lipid processing and inhibits degradation of corneodesmosomes. J Invest Dermatol 20010;130:500-510.
201. Ohman H, Vahlquist A: The pH gradient over the stratum corneum differs in X-linked recessive and autosomal dominant ichthyosis: A clue to the molecular origin of the 'acid skin mantle'? J Invest Dermatol 1998;111:674-677.
202. Abraham W, Wertz PW, Landmann L, Downing DT: Stratum corneum lipid liposomes: Calciuminduced transformation into lamellar sheets. J Invest Dermatol 1987;88:212-214.
203. Hatfield RM, Fung LW: A new model system for lipid interactions in stratum corneum vesicles: Effects of lipid composition, calcium, and pH. Biochemistry 1999;38:784-791.
204. Sidransky E: Gaucher disease: Complexity in a 'simple' disorder. Mol Genet Metab 2004;83:6-15.
205. Sidransky E, Fartasch M, Lee RE, et al: Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res 1996;39: 134-141.
206. Stone DL, Carey WF, Christodoulou J, et al: Type 2 Gaucher disease: The collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed 2000; 82:F163-F166.
207. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993;91:1656-1664.
208. Schmuth M, Man MQ, Weber F, et al: Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin- ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000;115: 459-466.
209. Schmuth M, Weber F, Paschke E, Sepp N, Fritsch P: Delayed epidermal permeability repair in patients with sphingomyelinase deficiency (Niemann-Pick disease). J Invest Dermatol 1999;112:542.
210. Uchida Y, Hara M, Nishio H, et al: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000;41:2071-2082.
211. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian epidermal barrier function: Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991;88: 1338-1345.
212. Holleran WM, Ginns EI, Menon GK, et al: Consequences of beta-glucocerebrosidase deficiency in epidermis: Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994;93: 1756-1764.
213. Jensen JM, Schutze S, Forl M, Kronke M, Proksch E: Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999;104:1761-1770.
214. Marsh NL, Elias PM, Holleran WM: Glucosylceramides stimulate murine epidermal hyperproliferation. J Clin Invest 1995;95:2903-2909.
215. Milger K, Herrmann T, Becker C, et al: Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4. J Cell Sci 2006;119: 4678-4688.
216. Harris IR, Farrell AM, Memon RA, Grunfeld C, Elias PM, Feingold KR: Expression and regulation of mRNA for putative fatty acid transport related proteins and fatty acyl CoA synthase in murine epidermis and cultured human keratinocytes. J Invest Dermatol 1998;111:722-726.
217. Schmuth M, Ortegon AM, Mao-Qiang M, Elias PM, Feingold KR, Stahl A: Differential expression of fatty acid transport proteins in epidermis and skin appendages. J Invest Dermatol 2005;125:1174-1181.
218. Jia Z, Moulson CL, Pei Z, Miner JH, Watkins PA: Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts. J Biol Chem 2007;282:20573-20583.
219. Ziboh VA, Chapkin RS: Metabolism and function of skin lipids. Prog Lipid Res 1988;27:81-105.
220. Anton-Lamprecht I: Diagnostic ultrastructure of non-neoplastic diseases; in Papadimitriou J, Spagnolo D (eds): The Skin. Edinburgh, Churchill Livingstone, 1992, pp 459-550.
221. Williams ML, Elias PM: From basketweave to barrier: Unifying concepts for the pathogenesis of the disorders of cornification. Arch Dermatol 1993;129: 626-629.
222. Akiyama M: The pathogenesis of severe congenital ichthyosis of the neonate. J Dermatol Sci 1999;21:96-104.
223. Williams ML, Elias PM: Genetically transmitted, generalized disorders of cornification - the ichthyoses. Dermatol Clin 1987;5:155-178.
224. Nussey DH, Postma E, Glenapp P, Visser ME: Selection on heritable phenotypic plasticity in a wild bird population. Science 2005;310:304-306.
225. Akiyama M, Sugiyama-Nakagiri Y, Sakai K, et al: Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest 2005;115:1777-1784.
226. Kelsell DP, Norgett EE, Unsworth H, et al: Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet 2005; 76:794-803.
227. Sakai K, Akiyama M, Sugiyama-Nakagiri Y, McMillan JR, Sawamura D, Shimizu H: Localization of ABCA12 from Golgi apparatus to lamellar granules in human upper epidermal keratinocytes. Exp Dermatol 2007;16:920-926.
228. Hollenstein K, Frei D, Locher K: Structure of an ABC transporter in complex with its binding protein. Nature 2007;446:213-216.
229. Allikmets R, Gerrard B, Hutchinson A, Dean M: Characterization of the human ABC superfamily: Isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet 1996;5:1649-1655.
230. Borst P, Elferink RO: Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002;71: 537-592.
231. Dean M, Rzhetsky A, Allikmets R: The human ATPbinding cassette (ABC) transporter superfamily. Genome Res 2001;11:1156-1166.
232. Jiang YJ, Lu B, Kim P, et al: PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. J Invest Dermatol 2008;128:104-109.
233. Thomas AC, Cullup T, Norgett EE, et al: ABCA12 is the major harlequin ichthyosis gene. J Invest Dermatol 2006;126:2408-2413.
234. Elias PM, Fartasch M, Crumrine D, Behne M, Uchida Y, Holleran WM: Origin of the corneocyte lipid envelope (CLE): Observations in harlequin ichthyosis and cultured human keratinocytes. J Invest Dermatol 2000;115:765-769.
235. Yamanaka Y, Akiyama M, Sugiyama-Nakagiri Y, et al: Expression of the keratinocyte lipid transporter ABCA12 in developing and reconstituted human epidermis. Am J Pathol 2007;171:43-52.
236. Dale BA, Holbrook KA, Fleckman P, Kimball JR, Brumbaugh S, Sybert VP: Heterogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization: Variable morphology and structural protein expression and a defect in lamellar granules. J Invest Dermatol 1990;94:6-18.
237. Milner ME, O'Guin WM, Holbrook KA, Dale BA: Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol 1992;99:824-829.
238. Uchida Y, Holleran WM, Elias PM: On the effects of topical synthetic pseudoceramides: Comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides. J Dermatol Sci 2008;51:37-43.
239. Choate KA, Williams ML, Elias PM, Khavari PA: Transglutaminase 1 expression in a patient with features of harlequin ichthyosis: Case report. J Am Acad Dermatol 1998;38:325-329.
240. Rassner UA, Crumrine DA, Nau P, Elias PM: Microwave incubation improves lipolytic enzyme preservation for ultrastructural cytochemistry. Histochem J 1997;29:387-392.
241. Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T: A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005;124: 198-203.
242. Caubet C, Jonca N, Brattsand M, et al: Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004;122:1235-1244.
243. Horikoshi T, Igarashi S, Uchiwa H, Brysk H, Brysk MM: Role of endogenous cathepsin D-like and chymotrypsin- like proteolysis in human epidermal desquamation. Br J Dermatol 1999;141:453-459.
244. Zeeuwen PL: Epidermal differentiation: The role of proteases and their inhibitors. Eur J Cell Biol 2004; 83:761-773.
245. Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M, et al: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 2005; 77:242-251.
246. Saba TG, Montpetit A, Verner A, et al: An atypical form of erythrokeratodermia variabilis maps to chromosome 7q22. Hum Genet 2005;116:167-171.
247. Montpetit A, Cote S, Brustein E, et al: Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Genet 2008;4:e1000296.
248. Gissen P, Johnson CA, Morgan NV, et al: Mutations in VPS33B, encoding a regulator of SNAREdependent membrane fusion, cause arthrogryposisrenal dysfunction-cholestasis (ARC) syndrome. Nat Genet 2004;36:400-404.
249. Hershkovitz D, Mandel H, Ishida-Yamamoto A, et al: Defective lamellar granule secretion in arthrogryposis, renal dysfunction, and cholestasis syndrome caused by a mutation in VPS33B. Arch Dermatol 2008;144:334-340.
250. Gissen P, Tee L, Johnson CA, et al: Clinical and molecular genetic features of ARC syndrome. Hum Genet 2006;120:396-409.
251. Coleman RA, Van Hove JL, Morris CR, Rhoads JM, Summar ML: Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: Additional findings or a new syndrome (ARCC-NDI)? Am J Med Genet 1997;72:335-338.
252. Deal JE, Barratt TM, Dillon MJ: Fanconi syndrome, ichthyosis, dysmorphism, jaundice and diarrhoea - a new syndrome. Pediatr Nephrol 1990;4:308-313.
253. Eastham KM, McKiernan PJ, Milford DV, et al: ARC syndrome: An expanding range of phenotypes. Arch Dis Child 2001;85:415-420.
254. Elias PM, Cullander C, Mauro T, et al: The secretory granular cell: The outermost granular cell as a specialized secretory cell. J Invest Dermatol Symp Proc 1998;3:87-100.
255. Gonelle-Gispert C, Molinete M, Halban PA, Sadoul K: Membrane localization and biological activity of SNAP-25 cysteine mutants in insulin-secreting cells. J Cell Sci 2000;113:3197-3205.
256. Feng D, Crane K, Rozenvayn N, Dvorak AM, Flaumenhaft R: Subcellular distribution of 3 functional platelet SNARE proteins: Human cellubrevin, SNAP- 23, and syntaxin 2. Blood 2002;99:4006-4014.
257. Steegmaier M, Yang B, Yoo JS, et al: Three novel proteins of the syntaxin/SNAP-25 family. J Biol Chem 1998;273:34171-34179.
258. Ugur O, Jones TL: A proline-rich region and nearby cysteine residues target XLalphas to the Golgi complex region. Mol Biol Cell 2000;11:1421-1432.
259. Hohenstein AC, Roche PA: SNAP-29 is a promiscuous syntaxin-binding SNARE. Biochem Biophys Res Commun 2001;285:167-171.
260. Wong SH, Xu Y, Zhang T, et al: GS32, a novel Golgi SNARE of 32 kDa, interacts preferentially with syntaxin 6. Mol Biol Cell 1999;10:119-134.
261. Hepp R, Langley K: SNAREs during development. Cell Tissue Res 2001;305:247-253.